JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 23 April 2009

Journal of Endocrinology 2009;203:1.

Journal of Endocrinology (2009) In press
DOI: 10.1677/JOE-09-0037
© 2009 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-09-0037v1
203/1/1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leney, S.
Right arrow Articles by Tavare, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leney, S.
Right arrow Articles by Tavare, J.

REVIEW

The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets

Sophie Leney and Jeremy Tavare

S Leney, Biochemistry, University of Bristol, Bristol, United Kingdom
J Tavare, Biochemistry, University of Bristol, Bristol, BS8 1TD, United Kingdom

Correspondence: Jeremy Tavare, Email: j.tavare{at}bristol.ac.uk

The search for the underlying mechanism through which insulin regulates glucose uptake into peripheral tissues has unveiled a highly intricate network of molecules which function in concert to elicit the redistribution or translocation of the glucose transporter isoform GLUT4 from intracellular membranes to the cell surface. Following recent technological advances within this field, this review aims to bring together the key molecular players which are thought to be involved in GLUT4 translocation and will attempt to address the spatial relationship between the signalling and trafficking components of this event. We will also explore the degree to which components of the insulin signalling and GLUT4 trafficking machinery may serve as potential targets for the development of orally available insulin mimics for the treatment of type I diabetes mellitus.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Society for Endocrinology.